
## **Trustees’ Annual Report for the period** 

## **From: 1 September 2023   To: 31 August 2024** 

## **Charity name: MEDLIFE UK** 

## **Charity registration number: 1176904** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|**1. THE PREVENTION OR RELIEF OF**<br>**POVERTY FOR THE BENEFIT OF**<br>**THE PUBLIC;**<br>**2. THE ADVANCEMENT OF**<br>**EDUCATION FOR THE BENEFIT**<br>**OF THE PUBLIC;**<br>**3. THE ADVANCEMENT OF HEALTH**<br>**FOR THE BENEFIT OF THE**<br>**PUBLIC; IN PARTICULAR, BUT**<br>**WITHOUT LIMITATION, THROUGH**<br>**THE PROVISION OF PRIMARY**<br>**CARE SERVICES, HEALTH**<br>**EDUCATIONAL PROGRAMMES**<br>**AND COMMUNITY DEVELOPMENT**<br>**PROJECTS AND (SAVE FOR**<br>**PURPOSES INCIDENTAL AND**<br>**ANCILLARY TO THE ABOVE**<br>**OBJECTS), NO OTHER**<br>**PURPOSES.**|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or services<br>identified in the accounts.|Para 1.17 and<br>1.19|**Medlife UK provides funding to projects**<br>**in Peru, Ecuador, Tanzania and Costa**<br>**Rica through their network of Chapters in**<br>**the UK. Chapters are school clubs**<br>**created at school and universities in the**<br>**UK. The projects are focused on**<br>**improving living conditions for**<br>**impoverished communities that lack**<br>**access to healthcare, sanitation and**<br>**proper housing. Medlife envisions to**<br>**partner with these communities to**<br>**develop long term relationships that will**<br>**provide aid to its members in any way**<br>**possible**<br>**During the year, the charity was**<br>**preparing to establish operations in the**<br>**UK.**|





||Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|**MEDLIFE UK has carried out its duty with**<br>**regard to the public benefit and the**<br>**objectives of the charity.**|
|---|---|---|---|



## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|**During the year the charity has**<br>**safeguarded charitable funds under its**<br>**care while it prepares to establish**<br>**operations in the UK.**|
|**Financial Review**|||
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|**The charity held bank & cash balances**<br>**totalling £4,475 as at 31 August 2024.**|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|**Currently, Medlife UK has no formal**<br>**policy for reserves since most of its**<br>**activities include fundraising activities.**<br>**The student travel portion for service**<br>**trips are currently being managed by the**<br>**parent company, Medlife USA. All**<br>**fundraising activities have a determined**<br>**project or goal towards which they must**<br>**be allocated and the charity will seek to**<br>**establish a formal reserves policy as it**<br>**grows and becomes financially**<br>**independent.**|
|Amount of reserves held|Para 1.22|**Free reserves amounted to £4,475 as at**<br>**31 August 2024.**|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|**The charity is governed by its**<br>**Constitution**|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|**The charity is constituted as a Charitable**<br>**Incorporated Organisation**|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|**Charity Trustees shall be appointed for a**<br>**term of three years by a decision of the**<br>**Appointing Trustees which may be taken:**<br>**(a) at a meeting of the Charity**<br>**Trustees;**<br>**(b) or by a resolution In Writing or**<br>**electronic form agreed by all of the**<br>**Appointing Trustees for the time**<br>**being.**<br>**In selecting individuals for appointment**<br>**as appointed Charity Trustees, the**<br>**Appointing Trustees must:**<br>**(a) have regard to the skills,**<br>**knowledge and experience needed**<br>**for the effective administration of**<br>**the CIO; and**<br>**(b) use their reasonable endeavours**<br>**to ensure that at all times a**<br>**majority of the Charity Trustees**<br>**are officers or employees of the**<br>**Founder Member.**|



## **Reference and Administrative details** 

|Charity name|MEDLIFE UK|
|---|---|
|Other name the charity uses||
|Registered charity number|1176904|
|Charity’s principal address|2810 N Church PMB 57094<br>Wilmington<br>DE<br>19802-4447<br>United States|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee(if any)**|
|---|---|---|---|---|
||Anhelyv Vidal<br>Ascencios|Trustee|||
||Jose Carols<br>Benavides<br>Hinojosa|Trustee|||
||Juan Camilo<br>Vanegas|Trustee|||
||Martha Patricia<br>Chicaiza Macas|Trustee|||
||Dr Nicolas Gerard<br>Ellis|Trustee and Chair|||
||Thomas Adam<br>Stephens|Trustee|||
||Jonathan Ross<br>Harrison|Trustee|Appointed 24 January<br>2023||



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 


**----- Start of picture text -----**<br>
Signature(s)<br>Full name(s)  Nick Ellis<br>    Position (eg Secretary,<br>Chair, etc)  President<br>Date<br>25 June 2025<br>**----- End of picture text -----**<br>





**MEDLIFE UK No: 1176904 Receipts and payments accounts CC16a For the period** 1 September 2023 31 August 2024 **To from** 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**9**<br>**60**<br>**216**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **276**<br>**-**<br>**-**<br> **-**<br>**276**<br>**-                    267**<br>**-**<br>**4,742**<br>**4,475**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**9**<br>**60**<br>**216**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**276**<br>**-**<br>**-**<br>**-**<br>**276**<br>**-                    267**|**Total funds**<br>**to the nearest £**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**9**<br>**-**<br>**-**<br>**-**<br>**9**<br>**60**<br>**216**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**276**<br>**-**<br>**-**<br>**-**<br>**276**<br>**-                    267**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|
|Donations|**-**||||||
|Bank interest|**9**|||||**9**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**9**|||||**9**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
|||||||**9**|
||||||||
|Bank charges|**60**|||||**60**|
|Other charges|**216**|||||**108**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**276**|||||**168**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**168**|
||||||||
||**-                    267**|**-**|**-**|**-                    267**||**-                   159**|
||**-**|**-**|**-**|**-**||**-**|
||**4,742**|**-**|**-**|**4,742**||**4,901**|
||**4,475**|**-**|**-**|**4,475**||**4,742**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>CAF Bank current account<br>**Details**<br>**Details**<br>**Details**<br>Signature|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**4,475**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**4,475**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Nick Ellis|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||||25 June 2025|
|||||



